| HYSCX | RITEX | HYSCX / RITEX | |
| Total Expense Ratio | 1.75 | 0.70 | 250% |
| Annual Report Gross Expense Ratio | 1.80 | 0.70 | 257% |
| Fund Existence | 14 years | 24 years | - |
| Gain YTD | 0.818 | 1.583 | 52% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.18B | 28.5B | 18% |
| Annual Yield % from dividends | 5.35 | 6.30 | 85% |
| Returns for 1 year | 4.22 | 7.06 | 60% |
| Returns for 3 years | 22.09 | 31.20 | 71% |
| Returns for 5 years | 19.08 | 25.64 | 74% |
| Returns for 10 years | 50.62 | 80.82 | 63% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 36.32 | 0.49 | +1.37% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| JFR | 7.65 | 0.05 | +0.66% |
| Nuveen Floating Rate Income Fund | |||
| IBGA | 24.35 | 0.04 | +0.16% |
| iShares iBonds Dec 2044 Term Trsy ETF | |||
| EVIM | 53.24 | -0.04 | -0.07% |
| Eaton Vance Intermediate Muncpl Inc ETF | |||
| COLO | 43.54 | -0.67 | -1.52% |
| Global X MSCI Colombia ETF | |||